The Ni atom at the catalytic center of [NiFe] hydrogenases is incorporated by a Ni-metallochaperone, HypA, and a GTPase/ATPase, HypB. We report the crystal structures of the transient complex formed between HypA and ATPase-type HypB (HypB AT ) with Ni ions. Transient association between HypA and HypB AT is controlled by the ATP hydrolysis cycle of HypB AT, which is accelerated by HypA. Only the ATP-bound form of HypB AT can interact with HypA and induces drastic conformational changes of HypA. Consequently, upon complex formation, a conserved His residue of HypA comes close to the N-terminal conserved motif of HypA and forms a Ni-binding site, to which a Ni ion is bound with a nearly square-planar geometry. The Ni binding site in the HypAB AT complex has a nanomolar affinity (K d = 7 nM), which is in contrast to the micromolar affinity (K d = 4 μM) observed with the isolated HypA. The ATP hydrolysis and Ni binding cause conformational changes of HypB AT , affecting its association with HypA. These findings indicate that HypA and HypB AT constitute an ATP-dependent Ni acquisition cycle for [NiFe]-hydrogenase maturation, wherein HypB AT functions as a metallochaperone enhancer and considerably increases the Ni-binding affinity of HypA.
X-ray crystallography | metalloprotein | transient complex | metallochaperone A pproximately one-half of all cellular proteins require specific metal ions for proper function, which are delivered by specific metallochaperones (1, 2) . However, the mechanisms of correct acquisition and delivery to target proteins of many metallochaperones remain poorly understood. [NiFe] hydrogenases harbor a complex metal cofactor, NiFe(CN) 2 CO, in their active sites (3). This cofactor catalyzes reversible H 2 production. The Ni atom in the NiFe(CN) 2 CO cofactor is bound to four thiolate groups, two of which also bridge the Fe(CN) 2 CO group (4, 5) . NiFe(CN) 2 CO biosynthesis requires specific maturation machinery, in which six Hyp proteins (HypA-HypF) play key roles (6, 7) . Four Hyp proteins (HypC-HypF) are involved in the biosynthesis and incorporation of the Fe(CN) 2 CO group (8) (9) (10) (11) (12) (13) (14) (15) . After Fe insertion, HypA and HypB insert the Ni ion into the hydrogenase large subunit (16) .
HypA is a Ni-metallochaperone that binds to a Ni ion with micromolar affinity (17) (18) (19) , and its structure consists of a Ni-binding domain (NiBD) and a Zn-binding domain (ZnBD) (20, 21) . The NiBD contains a highly conserved MHE motif that is essential for Ni binding at the N terminus (20, 22) . HypB consists of a common GTPase domain and a less conserved metal-binding region (23) (24) (25) . Recently, ATPase-type HypB (HypB AT , previously abbreviated as mmHypB) proteins were identified from Thermococcales (26) . GTPase and ATPase types of HypB belong to the SIMIBI class NTPase family and share a similar architecture, despite their low sequence similarity (27) . HypA and HypB form a transient complex in the Ni insertion process (17, 22, 28, 29) . In the Escherichia coli system, Ni transfer occurs from HypB to HypA (30) . However, the functional relationship between HypA and HypB or HypB AT for the maturation process is not fully understood. Here, we determined the crystal structures of the HypAHypB AT complex from Thermococcus kodakarensis, providing the structural basis of concerted actions of these proteins for Ni insertion in the [NiFe]-hydrogenase maturation process.
Results

ATP-Dependent Interaction Between
HypA and HypB AT . HypB AT is an ATPase, showing a significant ATPase activity (Fig. 1A) . The ATPase activity of HypB AT was further increased by threefold in the presence of HypA, suggesting that HypA enhances the ATPase activity of HypB AT through interaction with HypB AT .
We examined interactions between the two proteins in the presence or absence of nucleotide by size exclusion chromatography (SEC) (Fig. 1B and Fig. S1 ). ADP or ATPγS-bound HypB AT forms a stable homodimer in solution. However, elution
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The metal ions in proteins are correctly incorporated by specific metallochaperones. However, it remains unclear how metallochaperones regulate their metal binding affinity during acquisition of correct metal ions and deliver them to target proteins. In this study, we have determined the crystal structures of a transient complex between a Ni metallochaperone HypA and its partner ATPase protein HypB AT , which incorporate a Ni ion into [NiFe] hydrogenase. The structures reveal that HypB AT induces conformational change of HypA through complex formation, leading to formation of a Ni binding site. Consequently, the Nibinding affinity of HypA is increased from micromolar to nanomolar range (by ∼600-fold). These results indicate that HypB AT functions as a metallochaperone enhancer, which regulates metal binding affinity of metallochaperones.
volume of nucleotide-free HypB AT corresponded to a molecular mass between monomeric and dimeric state (∼40 kDa), suggesting that nucleotide-free HypB AT exists in rapid equilibrium between monomer and dimer. SEC experiments showed that ATPγS-bound HypB AT weakly interacts with HypA, forming a binary complex at a molar ratio of 2:2 ( Fig. S1A) . However, nucleotide-free or ADP-bound HypB AT did not show complex formation with HypA ( Fig. S1 B and C) . These results indicate that association and dissociation of HypA and HypB AT is regulated by the ATP hydrolysis cycle of HypB AT.
Overall Structure of the HypA-HypB AT Complex. To elucidate the molecular mechanisms underlying HypA-HypB AT interactions, we determined the crystal structure of the HypAB AT complex at 1.63-3.10 Å resolution in the presence of (i) ATPγS and Ni ions; (ii) AMPPCP (a nonhydrolyzed ATP analog) and Ni ions; and (iii) only AMPPCP ( Fig. 2A and Table S1 ). The overall architectures of these three states are similar, despite small differences in local conformations (Fig. S2 ). In the case of the presence of ATPγS and Ni ions, although ATPγS was slowly hydrolyzed in the crystal, its overall architecture was retained, owing to tight crystal packing (Fig. S3) .
The HypB AT monomer structure consists of a central eightstranded β-sheet (β1-β8) flanked by nine α-helices (α1-α9) (Fig.  S4A) , and forms a homodimer. The AMPPCP/ADP molecules are sandwiched at the dimer interface. The HypA structure consists of the NiBD and ZnBD (Fig. S4B) . The ZnBD is composed of two α-helices, a short three-stranded β-sheet (β3, β4, and β5) and a zinc finger motif (CXXCXnCPXC), in which a Zn ion is coordinated by four cysteine residues (Fig. S4C) . The NiBD is composed of two α-helices (α1 and α2) and a threestranded β-sheet (β1, β2, and β6). In the presence of Ni ions, the conserved MHE motif binds a Ni ion (details described below).
The structure of the HypAB AT complex shows a heterotetrameric structure containing two HypA and two HypB AT molecules ( Fig. 2A) . The two HypA molecules are bound to the opposite surface of the ATP-binding site of the HypB AT dimer. The HypAB AT complex is formed through three interfaces (Fig. 2B) . At interface 1, the HypB AT α1 helix is unwound from Pro6, and residues 2-6 adopt β-strand conformations, interacting with a hydrophobic patch between the α1 helix and β6 strand in the HypA-NiBD (Fig. 2B , Upper and C). At interface 2, the α3, η4, and α4 helices in the HypA-ZnBD interact with the β6-α4 and α3-β4 loops of HypB AT through hydrophobic interactions and several hydrogen bonds (Fig. 2B , Lower and D). Interface 3 involves hydrogen bonds between residues surrounding the HypA zinc finger motif and the α5′ and α6´helices of HypB AT (where the prime indicates the second HypB AT in the dimer) (Fig. 2B , Lower and E), suggesting that the dimeric form of HypB AT is required for complex formation with HypA. The residues involved in the three interfaces are well conserved in both proteins (Figs. S5 and S6).
Complex Formation Creates a Ni-Binding Site with Nanomolar Affinity. Upon complex formation, HypA undergoes striking conformational changes (Fig. 3A, Fig. S5 , and Movie S1). In a superposition of the isolated form of HypA with that in the HypAB AT complex, there is steric and electrostatic repulsion between HypA-Glu119 and HypB AT -Glu109, and between HypA-Asp117 and HypB AT -Glu177´(Movie S1). To avoid the repulsion, the ZnBD in the complex is substantially rotated clockwise, and the η2, η3, and η4 3 10 helices are moved toward HypB AT (Fig. 3A, Right) , leading to formation of the interfaces 2 and 3 ( Fig. 2 D and E) . This movement disrupts a hydrophobic core formed by Phe89, Ile97, Phe99, and Phe107 in the isolated state. Consequently, Phe99 is flipped out, and Ile93 moves into the hydrophobic core, resulting in formation of the α3 and α4 helices. These conformational changes bring a conserved His residue (HypA-His98) close to the conserved MHE motif, forming a Ni-binding site (Fig. 3B) . The Ni ion bound to this site has a nearly square-planar geometry, coordinated by the amine nitrogen of Met1, the amide nitrogen and Nδ of His2, and Ne of His98. Oe of Glu3 also exhibits van der Waals interactions (3.8 Å) with the Ni ion, further supporting the coordination of the Ni ion.
To determine how HypB AT affects the Ni-binding property of HypA, we performed isothermal titration calorimetry (ITC) experiments ( Fig. 3C and Table S2 ). HypA bound to a Ni ion with a K d value of 4.1 μM (Fig. 3C , Left), but no Ni binding to ATPγS-bound HypB AT was observed (Fig. 3C , Middle). Furthermore, the ITC data for equal molar mixtures of HypA and HypB AT with ATPγS revealed a strong and a weak binding site (Fig. 3C , Right). The best-fit parameters obtained by a two-site model were K d1 = 7.3 nM and K d2 = 6.6 μM, for the strong and weak sites, respectively. Under the experimental conditions, HypAB AT complex and isolated HypA and HypB AT were observed in the sample cell (Fig. 1B) . The binding parameters for the weak site (K d2 ) were comparable to those of isolated HypA. The strong binding site (K d1 ) with nanomolar affinity corresponds to the observed Ni-binding site in the HypAB AT complex. These results indicate that complex formation increases the Ni-binding affinity of HypA from micromolar to nanomolar range by formation of the Ni-binding site with the square-planar coordination.
Conformational Changes by ATP Hydrolysis and Ni Binding. Conformational changes induced by ATP hydrolysis of HypB AT account for the ATP-dependent interaction of HypB AT with HypA. Despite lack of the structures of ATP-bound HypB AT alone, HypB AT in the HypAB AT complex can be regarded as an "ATPbound state," because only the HypB AT bound to ATP or ATP analogs interacts with HypA. Upon ATP hydrolysis, the Walker A and B motifs undergo outward and inward rotations, respectively ( Fig. 4A and Fig. S3 ). These conformational changes displace the β6-α4 loop and α4 helix of HypB AT and, consequently, affect interface 2 of HypB AT (Fig. 4B ). In the HypAB AT complex, the hydrophobic cleft at interface 2 accommodates Phe99, Ile100, and Val103 of HypA (Figs. 2D and 4B, Left). However, interface 2 of ADP-bound HypB AT alone shows a flat molecular surface (Fig. 4B , Middle). The nucleotide-free state of HypB AT also shows a different molecular surface at interface 2 ( Fig. 4B, Right) . In addition, the ADP-bound HypB AT dimer adopts a more open configuration (Fig.  4C ), affecting interface 3. Therefore, conformational changes induced by ATP hydrolysis impair the interactions of HypB AT with HypA by disrupting interfaces 2 and 3. Ni binding to the HypAB AT complex also affects the HypAHypB AT complex interfaces. Comparison of the Ni-free and Nibound structures shows that upon Ni binding, the HypA-NiBD is slightly rotated and the N terminus moves toward His98 to form the Ni-binding site (Fig. 4D ). This conformational change slightly displaces the NiBD of HypA from HypB AT (Fig. 4E) , suggesting that Ni binding to the HypAB AT complex weakens the interactions. However, the ZnBD in the Ni-bound state is nearly identical to that in the Ni-free state. The observation that the coordination of Zn site in Helicobacter pylori HypA (HpHypA) is dynamic, depending on pH and Ni binding (19) appears to be a specific property of HpHypA, because the His residues involved in Zn binding in HpHypA are not conserved among other HypA homologs including T. kodakarensis HypA.
Discussion
The present study shows that the transient complex formation between HypA and HypB AT induces conformational changes of HypA, resulting in >560-fold enhancement of the Ni binding affinity of HypA. The association and dissociation of the HypAB AT complex are regulated by the ATP-hydrolysis cycle of HypB AT . Based on the present findings, we propose the following mechanism for an ATP-dependent Ni acquisition cycle in [NiFe]-hydrogenase maturation (Fig. 5) . ATP-bound HypB AT interacts with HypA and induces conformational changes in the ZnBD of HypA. Consequently, the conserved His residue comes close to the MHE motif, forming the Ni-binding site with nanomolar affinity. HypA rapidly traps a Ni ion with the nanomolar affinity site. Upon Ni binding, the conformational changes in HypA affect its association with HypB AT , and complex formation stimulates ATP hydrolysis of HypB AT , thereby disrupting the complex interfaces, leading to release of HypA from HypB AT . Subsequently, HypA reassumes the micromolar affinity form, either spontaneously or by association with the hydrogenase large subunit, and inserts the Ni ion into the large subunit (31, 32) . Sequence analysis suggests that the functional roles of HypB AT in the ATP-dependent Ni acquisition cycle are conserved among all HypB AT proteins, although HypB AT homologs including that from T. kodakarensis do not have a Ni binding site like those found in the conserved G domain of HypB (Fig. S6) .
The structures of the HypAB AT complex determined herein provide insight into the interactions of HypB with HypA. A HypB-binding site of HpHypA is located at the cleft between the α1 helix and β6 strand (29) , which is consistent with interface 1 of HypA. Hydrophobic residues at the N-terminal or linker region of HypB were shown to be involved in its interaction with HypA (28, 29) . Thus, interface 1 is likely to be conserved among all HypA and HypB protein types.
The metal-binding affinities of metallochaperones are tightly controlled during the trafficking of specific metal ions. Micromolar affinity is preferable for delivering metal ions into target proteins, but is insufficient for acquiring metal ions at low concentration in the cytoplasm (33) . In this study, HypB AT increased the Ni-binding affinity of HypA from the micromolar to nanomolar range. Because nanomolar affinity is sufficient for specific binding for the Ni ion, HypB AT appears to function as a metallochaperone enhancer that increases the metal-binding affinity of the target metallochaperone (HypA). The concept of metallochaperone enhancer can account for the previous generic observations that disruption of the hypB AT gene resulted in a significant defect in [NiFe]-hydrogenase maturation (26) . Without HypB AT , HypA cannot adopt the high-affinity form for Ni ions and, therefore, fails to acquire and transfer Ni ions. This defect can be restored by Ni supplementation, because increasing the cellular Ni concentration allows HypA to deliver Ni ions to the hydrogenase large subunit. Thus, metallochaperone enhancer is essential for effective acquisition and delivery of specific metal ions by metallochaperone. We believe that these findings will provide a general model for the functional regulation of metallochaperones.
Materials and Methods
For crystallization, the HypAB AT complex sample was prepared by mixing the two proteins at an equal molar concentration and 1 mM ATP analog (ATPγS or AMPPCP) with or without 1 mM NiCl 2 for 1-2 h at room temperature. Crystals of the HypAB AT complex were obtained by using MgCl 2 and PEG 3350 as precipitates. The X-ray diffraction data were collected at the BL1A and AR-NE3A beamlines at the Photon Factory and the BL41XU beamline at SPring-8 and were processed with the HKL2000 package (34) . The structure of the HypAB AT complex was determined by the molecular replacement method with Molrep (35) and Phaser (36) , using the previously determined HypA (PDB ID code 3A43) and HypB AT (PDB ID code 3VX3) as search models. The structures were refined with PHENIX (37) and validated with MolProbity (38) . The Ni atoms in the crystal structures were confirmed with dataset collected at the peak and edge wavelengths of Ni (Table S1 ). More detailed experimental procedures are described in SI Materials and Methods.
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SI Materials and Methods
Protein Expression and Purification. Overexpression and purification of HypA and HypB AT were performed as described (1, 2) , with the following modifications. All chromatography procedures were performed at room temperature by using the ÄKTA explorer system (GE Healthcare). For HypA, the heat-treated supernatant was applied onto an anion-exchange column (HiTrap Q; GE Healthcare) equilibrated with buffer A (50 mM Tris-HCl, pH 8.0, and 1 mM DTT). Proteins were eluted with a linear gradient of NaCl from 0.15 to 0.4 M. The eluted sample was concentrated and applied to a size-exclusion column (Superdex200 10/300 GL; GE Healthcare) equilibrated with buffer B [20 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 1 mM Tris(2-carboxyethyl)phosphine (TCEP)].
For HypB AT , the heat-treated supernatant was applied onto an anion-exchange column (HiTrap Q) equilibrated with buffer A. Proteins were eluted with a linear gradient of NaCl from 0.15 to 0.5 M. The eluted sample was concentrated and applied to a size-exclusion column (Superdex200 10/300 GL) equilibrated with buffer B containing 1 mM DTT instead of TCEP. To remove ADP bound to the protein, the eluted HypB AT was diluted overnight to ∼10 μM with buffer A. After heat treatment at 333 K for 1 h, the diluted sample was applied onto a desalting column (HiPrep 26/10 Desalting; GE Healthcare) equilibrated with buffer A. The eluted sample was concentrated and applied to a size-exclusion column (Superdex75 10/300 GL; GE Healthcare) equilibrated with buffer C (20 mM Hepes-Na pH 7.5, 150 mM NaCl, and 5 mM MgCl 2 ).
ATPase Assay. ATP hydrolysis activities were assayed by using a colorimetric ATP assay kit from Innova Biosciences. A 100-μL reaction solution contained 5 μM protein (HypA, HypB AT , or HypA and HypB AT ), 20 mM Hepes-Na pH 7.5, 150 mM NaCl, 5 mM MgCl 2 , and 0.5 mM ATP. The reaction solution was incubated at 358 K for 5 min, followed by addition of Gold mix to stop the reaction. After 2-min incubation on ice, a stabilizer was added and then the reaction solution was further incubated for 30 min on ice. The absorbance of the solution was measured at 620 nm to measure the amount of phosphate released from ATP. The baseline was obtained by measuring absorbance of the reaction solution without proteins.
SEC Analyses of Interactions Between HypA and HypB AT . SEC analyses were performed with a Superdex75 10/300 GL column equilibrated with buffer C. The sample solution containing 40 μM HypA and 40 μM HypB AT , with or without 1 mM nucleotide in buffer C, was incubated overnight at room temperature. The molecular masses of all peaks were determined by comparing the elution volume to those of the marker proteins, aldolase (158 kDa), conalbumin (75 kDa), and ribonucleaseA (17.3 kDa) (Gel Filtration Calibration Kit; GE Healthcare).
Crystallization. All crystallizations were performed by the hangingdrop vapor-diffusion method at 293 K. Drops were equilibrated against 400 μL of reservoir solution. The HypAB AT complex sample was prepared by mixing the two proteins at an equal molar concentration (80-144 μM) in buffer C and 1 mM ATP analog (ATPγS or AMPPCP) with or without 1 mM NiCl 2 for 1-2 h at room temperature. The monoclinic crystals of the HypAB AT complex in the presence of ATPγS and Ni ions were grown in 1-2 d by mixing 0.7 μL of the complex sample with 0.7 μL of reservoir solution containing 100 mM Mes-Na pH 6.2, 500 mM MgCl 2 , and 20% (wt/vol) PEG 3350. The orthorhombic crystals of the same complex were obtained in 1-2 d by mixing 1 μL of the complex sample with 1 μL of reservoir solution containing 100 mM Mes-Na pH 6.2 or 8.4, 380-420 mM MgCl 2 , 18-19% (wt/vol) PEG 3350, and 5% (wt/vol) urea. Crystals of the AMPPCP-bound HypAB AT complex with or without Ni ions were also grown in 1-3 d by mixing 1 μL of the complex sample with 1 μL of reservoir solution containing 100 mM Mes-Na pH 6.2, 360 mM MgCl 2 , and 18-19% (wt/vol) PEG 3350 in addition to 5% (wt/vol) urea or 200 mM guanidine.
For the nucleotide-free HypB AT , the purified protein solution was concentrated to 5.9 mg/mL in buffer C. The crystals were obtained in 3 d by mixing 0.7 μL of the sample with 0.7 μL of reservoir solution containing 100 mM Mes-Na pH 5.6, 590 mM MgCl 2 , and 24% (wt/vol) PEG 3350.
For data collection, cryoprotectant solution containing 100 mM Mes-Na at the same pH as the reservoir solution, 500-600 mM MgCl 2 , 30% (wt/vol) PEG 3350, and 5% (vol/vol) glycerol was prepared. With respect to the orthorhombic crystals of the HypAB AT complex, 5% (wt/vol) urea or 200 mM guanidine was also added to the cryoprotectant. Each solution was added in the drops, and then the crystals were flash-frozen in a nitrogen stream.
Data Collection and Structure Determination. The X-ray diffraction data were collected at the BL1A and AR-NE3A beamlines at the Photon Factory and the BL41XU beamline at SPring-8. Diffraction images were processed with the HKL2000 package (3). The monoclinic crystal structure of the HypAB AT complex was determined by the molecular replacement method, using truncated models of the previously determined HypA (PDB ID code 3A43) and HypB AT (PDB ID code 3VX3) as search models. The site of HypB AT was first searched by using the program Molrep (4) and then the site of HypA was searched by Phaser (5) in PHENIX (6) . The initial electron density map after the molecular replacement was improved with Resolve (7) in PHENIX. The initial model was built with Buccaneer (8) . The orthorhombic crystal structure of the HypAB AT complex was determined by the molecular replacement method with the program Molrep, using its monoclinic structure as a search model. The structure of the nucleotide-free HypB AT was determined by the molecular replacement method with the program Molrep, using the previous HypB AT structure as a search model. All manual model buildings were performed with COOT (9) . The structures were refined with PHENIX and validated with MolProbity (10). The Ni atoms in the crystal structures were confirmed with datasets collected at the peak and edge wavelengths of Ni (Table S1 ). Structural figures were prepared with PyMOL (11) and Chimera (12) .
Isothermal Titration Calorimetry. Isothermal titration calorimetry experiments were performed by using the MicroCal iTC200 calorimeter (GE Healthcare). All measurements were performed in 20 mM Tris-HCl pH 7.5, 150 mM NaCl, and 5 mM MgCl 2 at 298 K. Typically, after a 0.4-μL initial injection, a NiCl 2 solution was injected into a protein solution at a 180-s interval with stirring at 700 rpm. For HypA, 24 injections of 1.5 μL of 1,120 μM In the presence of ADP or ATPγS (slowly hydrolyzed ATP analog), HypB AT exits in a homodimer, whereas the nucleotide-free state appears to be in a rapid equilibrium between monomer and dimer. . The HypB AT monomers of the two states are superimposed on each other. In the case of ATPγS, although ATPγS was slowly hydrolyzed in the crystal, the overall architecture is retained by tight crystal packing. In the AMPPCP-bound structure, replacement of the O3β atom of the β phosphate to carbon results in subtle displacement of residues in the Walker A and B motifs and those in the interface 2, leading to small rearrangement of HypA (Fig. S3 A and B) . 
